Skip to main content
Premium Trial:

Request an Annual Quote

William Sharp, Steven Stice

Premium
Aruna Biomedical announced this week that William Sharp has been named president and chief executive officer. Sharp has also been appointed to Aruna's board of directors. He succeeds Aruna founder Steven Stice,who will remain Aruna's chairman and chief scientific officer. 
 

Sharp most recently served as chief commercial officer of BioProcessors, a venture-financed life science tools developer based near Boston, Mass. Prior to BioProcessors, he was senior vice president of business development at Cellomics, vice president of business development at Gentra Systems, worldwide director for the molecular biology business of Life Technologies (now Invitrogen), and vice president of sales and marketing at Heraeus Instruments

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.